Companies · Software / Tech
MCLEAN · Software / Tech · refined from filed group “Other Health Care”
Diligence memoA one-page analyst read on CareSave Technologies, Inc. — recommendation, valuation, rhythm, risks.→CareSave Technologies, Inc. looks under-valued against its niche peers and is active on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
CareSave Technologies, Inc. is one of 3920 Software / Tech companies tracked from MCLEAN. By capital raised it ranks among the largest (ahead of 97% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 80%.
Round size and date are reported; the stage label is inferred from round size (latest is Series C — a $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.
Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 97% of sector peers (real $). Modeled value above 46% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #36 of 39.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Clay Labs Inc. | Series C | $140.3M | $700.9M | 1.94× |
| Alembic Technologies, Inc. | Series C | $123.0M | $644.1M | 1.78× |
| Federato Technologies, Inc. | Series C | $175.0M | $622.0M | 1.72× |
| Digital LinkBridge CO | Series C | $100.0M | $621.4M | 1.72× |
| Parler Technologies, Inc. | Series C | $100.0M | $611.2M | 1.69× |
| Touareg Group Technologies Co. | Series C | $100.0M | $607.7M | 1.68× |
| Exa Labs Inc. | Series C | $102.0M | $540.8M | 1.49× |
| Linus Technology NewCo, Inc. | Series C | $75.0M | $540.7M | 1.49× |
| Nikola Labs Inc. | Series C | $149.5M | $540.6M | 1.49× |
| Xona Space Systems Inc. | Series C | $115.3M | $525.5M | 1.45× |
| Omni Analytics, Inc. | Series C | $113.4M | $519.8M | 1.44× |
| Cicero Technologies, Inc. | Series C | $103.0M | $473.1M | 1.31× |
| CareSave Technologies, Inc. this company | Series C | $174.6M | $28.8M | 0.08× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $1.8M | 2015-06-04 | $9.0M | $61.5M | 85% |
| Series A | $11.0M | 2018-01-17 | $50.0M | $305.1M | 90% |
| Series A | $6.2M | 2019-08-02 | $28.4M | $173.0M | 90% |
| Series B | $17.7M | 2021-05-18 | $98.2M | $395.1M | 90% |
| Series C | $86.6M | 2022-12-20 | $577.4M | $1.3B | 90% |
| Series C | $47.0M | 2024-03-21 | $313.3M | $477.8M | 90% |
| Series C | $4.2M | 2025-07-21 | $28.3M | $28.8M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Todd Walrath | — | 2 other | 2015-06 |
| Anil Todd Vinayak | — | — | 2019-08 |
| Chistopher Todd Brandt | — | — | 2022-12 |
| Christopher Todd Brandt | — | — | 2021-05 |
| E. Todd Walrath | — | — | 2019-08 |
| Guljit Todd Khurana | — | — | 2019-08 |
| Mark Todd Buffington | — | — | 2025-07 |
| Matthew Todd Aprahamian | — | — | 2021-05 |
| Paul Todd Iaffaldano | — | — | 2021-05 |
| Sever Todd Totia | — | — | 2019-08 |
CareSave Technologies, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Baron App, Inc. | Software / Tech | Series C | $187.8M | $23.8M | same sector · same stage |
| Wildcat Discovery Technologies, Inc. | Software / Tech | Series C | $137.1M | $30.9M | same sector · same stage |
| Foursquare Labs, Inc. | Software / Tech | Series C | $319.0M | $28.1M | same sector · same stage |
| Zora Labs, Inc. | Software / Tech | Series C | $65.2M | $25.8M | same sector · same stage |
| QSpex Technologies Inc | Software / Tech | Series B | $90.2M | $30.5M | same sector |
| Pixxel Space Technologies, Inc. | Software / Tech | Series B | $68.0M | $32.7M | same sector |
| LIS Technologies Inc | Software / Tech | Series B | $64.5M | $28.7M | same sector |
| Pixelligent Technologies Llc | Software / Tech | Series A | $55.7M | $35.4M | same sector |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Carevive Systems, Inc. | Software / Tech | Series A | $414.9M | 86% |
| Surgicure Technologies, Inc. | Software / Tech | Seed | $11.0M | 86% |
| Carestarter Technologies Inc. | Software / Tech | Seed | $49.4M | 85% |
| Jump Technologies, Inc. | Software / Tech | Seed | $16.8M | 84% |
| Avisi Technologies, Inc. | Software / Tech | Series A | $64.5M | 82% |
| OPC Technology Ventures, LLC | Software / Tech | Series B | $623.2M | 82% |
| JenaValve Technology Inc | Software / Tech | Series D+ | $2.2B | 82% |
| Carebot Health, Inc. | Healthtech | Seed | $3.7M | 82% |
See where CareSave Technologies, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at CareSave Technologies, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.